A study of plasma homocysteine levels in type 2 diabetes mellitus and its correlation with diabetic retinopathy
DOI:
https://doi.org/10.7439/ijbr.v10i8.5221Keywords:
Case control study, Diabetic Retinopathy, Homocysteine, Reactive oxygen species, Prevention of further vascular damageAbstract
Introduction: Diabetic Retinopathy is an ocular manifestation of diabetes, asystemic disease, which affects up to 80 percent of all patients who have had diabetes for 20 years or more. Homocysteine (Hcy) is a highly reactive Thiol-containing amino acid derived from the conversion of methionine to cysteine, producing reactive oxygen species
Downloads
Downloads
Published
2019-08-31
Issue
Section
Original Research Articles
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- An author must submit Copyright form After acceptance of the article.
How to Cite
1.
A study of plasma homocysteine levels in type 2 diabetes mellitus and its correlation with diabetic retinopathy. Int Jour of Biomed Res [Internet]. 2019 Aug. 31 [cited 2025 Jul. 26];10(8):e5221. Available from: https://ssjournals.co.in/index.php/ijbr/article/view/5221